Lower observed-to-expected ratios were seen for cases diagnosed at localized versus advanced stages.
A new AI program can use images of a person’s body and organs to evaluate for cancer treatment within several minutes — much faster than current methods, researchers say.
The report highlights advances such as approval of 14 new anticancer therapeutics and the expansion of the use of 12 previously approved therapeutics.
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.
The chemicals already are illegal in the European Union and other places around the world.
A small implantable device, the size of a grain of rice, could be placed in the brain of cancer patients to help develop treatments, new research suggests.
Back-to-back climate-related disasters have hampered blood collection efforts, and a summer shortfall has made the shortage worse.
The authors urge greater transparency of study results for drugs approved by the FDA.
Increasing quartiles of MEDLIFE index were associated with reduced hazard ratios for all-cause and cancer mortality.
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
Please login or register first to view this content.